Quaker Wealth Management
EW icon

Quaker Wealth Management’s Edwards Lifesciences EW Stock Holding History

Quaker Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$53.1K Sell
615
-4
-0.6% -$355 0.02% 163
2026
Q2 		$56K Hold
619
– – 0.02% 157
2026
Q1 		$49.6K Buy
619
+7
+1% +$577 0.02% 162
2025
Q4 		$52.2K Buy
612
+1
+0.2% +$82 0.02% 162
2025
Q3 		$47.5K Hold
611
– – 0.02% 168
2025
Q2 		$47.8K Buy
+611
New +$45.6K 0.02% 164

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Quaker Wealth Management's EW Position: Q3 2026 in Review

Quaker Wealth Management reduced its Edwards Lifesciences (EW) stake by 0.65% in Q3 2026, selling an estimated $355 and leaving 615 shares worth $53.1K. The position accounts for 0.02% of the portfolio, ranked #163.

Quaker Wealth Management first reported a position in EW in Q2 2025 and has held it in 6 quarters since. The position peaked at $56K in Q2 2026. 713 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Quaker Wealth Management held 615 shares of Edwards Lifesciences worth $53.1K as of Q3 2026.
  • Quaker Wealth Management sold 4 Edwards Lifesciences shares in Q3 2026, an estimated $355.
  • Edwards Lifesciences made up 0.02% of Quaker Wealth Management's portfolio in Q3 2026, its #163 holding.
  • Quaker Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's Edwards Lifesciences position peaked at $56K in Q2 2026.
  • 713 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.